Unlocking the Potential of Genetic Innovation
Tsingke is a leading gene factory that specializes in providing a wide range of DNA/RNA services. Our services encompass Gene Synthesis, Oligo Synthesis, Protein Expression, Antibody and more. With state-of-the-art technology and a team of experienced scientists, we deliver high-quality solutions tailored to meet the diverse needs of our clients in fields such as biotechnology, pharmaceuticals, and academic research. Explore further to find out your ideal genetic service!
Tsynth™ Gene Synthesis
Tsingke provides top-tier genes, boasting lengths of up to 200 kb tailored to diverse research requirements. Genes come with Tsingke cloning vectors or a choice of 160+ custom vectors, all without cloning fees.
Oligo Synthesis
Tsingke offers versatile oligo solutions with 200 modifications and multiple purification options. Our efficient platform, equipped with cutting-edge synthesizers and stringent quality management system.
Protein Expression
One-stop service from gene to recombinant protein expression to meet customer's needs for specific applications.
Custom RNA Oligos
Tsingke privides various synthesis types available, such as sgRNA, siRNA, miRNA, etc and high quality through Mass Spectrometry and HPLC strict quality control.
Cell & Gene Therapy International 2024
September 23-26, 2024
Hynes Convention Center
Boston, MA
Learn More
About Tsingke
Tsingke is the pioneering DNA/RNA synthesis company, delivering reliable products and services for biotechnology research, drug development, etc. With over 200 modifications and multiple purification options, our custom oligos are of the highest quality at competitive prices. Leveraging cutting-edge R&D and automated production systems, we deliver top-tier gene synthesis and oligo synthesis services. Backed by cutting-edge technology and stringent quality control, Tsingke unlocks possibilities in genetics for various fields including IVD, antibody drug discovery, and synthetic biology solutions.
300,000
+
Customers
70,000
Operating Area
100,000
+
IF for Articles Citing Tsingke's Products
15,000
+
Citations
600
million base pair
Yearly Oligo Synthesis Capacity
200
kb
Capacity for Large Gene Synthesis
You’ll Find Tsingke Cited in More than Twelve Thousand Publications
Structure of the human PKD1-PKD2 complex
The codon-optimized full-length cDNAs for human PKD1 and PKD2 were synthesized by Tsingke Company (hPKD1 [Uniprot: P98161-1]; hPKD2 [Uniprot: Q13563-1])).
Structure of the human PKD1-PKD2 complex
Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction
Small interfering RNAs (siRNAs) targeting the Kdm4e (si-Kdm4e), Dux4 (si-Dux4), and scramble siRNA (si-NC) genes were constructed by Tsingke Biotechnology Co., Ltd. (Beijing, China).
Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction
MAMDC2, a gene highly expressed in microglia in experimental models of Alzheimers Disease, positively regulates the innate antiviral response during neurotropic virus infection
Our study uncovers the function of MAMDC2 in the innate antiviral response in microglia, revealing a potential mechanism linking HSV-1 and AD.-JOURNAL OF INFECTION, IF 38.637
MAMDC2, a gene highly expressed in microglia in experimental models of Alzheimers Disease, positively regulates the innate antiviral response during neurotropic virus infection
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
Signal Transduction and Targeted, IF 38.104
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation
In addition, a TaqMan-based qPCR assay was developed to test the clinical and duck samples with a set of probe and primers (synthesised by Tsingke Biotechnology, Beijing, China; appendix p 2) designed in this study, on the basis of the ompA gene sequence.
Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation
Strand-selective base editing of human mitochondrial DNA using mitoBEs
Wild-type TadA, TadA8e-V106W, MutH and its variants, Nt.BspD6I and other genes were synthesized as gene blocks and codon optimized for mammalian expression (Tsingke Biological Technology).
Strand-selective base editing of human mitochondrial DNA using mitoBEs
Conatct
Welcome to Contact Us!
We are here to help. Let's explore how we can assist you. Whether you have questions, suggestions, or collaboration opportunities, feel free to reach out. Our team is ready to provide support and discuss how we can best meet your needs.
Those with * are required